ROIV

#518
Roivant Sciences Ltd. - Common Shares
29.9 9 USD
+0.37%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
29.98
30.01
년간 변동
0.29
32.79
일일 변동
+0.37%
월간 변동
+7.53%
6달 변화
+46.43%
년간 변동율
+63.79%
이전 종가
29.8 8
Open
30.0 1
저가
29.9 8
High
30.0 1
양
326
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 21.57 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-51.3
주가매출액비율
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

뉴스